LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 71

Search options

  1. Article ; Online: Protocols to Manufacture an Oncolytic Measles Virus-Sensitive Immunocompetent Mouse Model of Medulloblastoma.

    Lal, Sangeet / Raffel, Corey

    Methods in molecular biology (Clifton, N.J.)

    2022  Volume 2423, Page(s) 165–177

    Abstract: Oncolytic virotherapy translational research in the current era is heavily focused on the interaction of the immune system and tumor microenvironment with oncolytic viruses. Preclinical xenograft studies using human cells in immunodeficient mouse models ... ...

    Abstract Oncolytic virotherapy translational research in the current era is heavily focused on the interaction of the immune system and tumor microenvironment with oncolytic viruses. Preclinical xenograft studies using human cells in immunodeficient mouse models does not serve this purpose. As a consequence, developing syngeneic immunocompetent murine cancer models sensitive to infection and growth of specific oncolytic viruses is required. The group 3 subtype of medulloblastoma, among the four molecular subgroups-WNT, SHH, Group 3, and Group 4, has the worst prognosis and the poorest outcome. Sadly, current treatments cause long-term toxicity and morbidity to survivors adversely affecting their quality of life. Alternate effective therapy with less side effects is urgently needed. We have shown that oncolytic measles virus (MV) is effective against localized as well as CSF-disseminated medulloblastoma in immunodeficient mouse models. To study the interaction of immune system with oncolytic measles virotherapy, we have developed a murine group 3 medulloblastoma cell line (CSCG) that is infectible by MV, is killed by MV, allows replication of MV, and is tumorigenic in the brain of syngeneic transgenic immune-competent mice. Intratumoral injection of MV results in significant prolongation of survival in mice bearing CSCG tumors in the brain. This model provides the first suitable platform to examine therapeutic regimens of MV therapy for MB tumors in the presence of intact immune system. Here, we describe our lab protocols to develop this cell line and the mouse model.
    MeSH term(s) Animals ; Cell Line, Tumor ; Cerebellar Neoplasms/therapy ; Humans ; Measles/therapy ; Measles virus/genetics ; Medulloblastoma/pathology ; Medulloblastoma/therapy ; Mice ; Mice, Nude ; Oncolytic Virotherapy/methods ; Oncolytic Viruses/genetics ; Quality of Life ; Tumor Microenvironment ; Xenograft Model Antitumor Assays
    Language English
    Publishing date 2022-01-03
    Publishing country United States
    Document type Journal Article
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-0716-1952-0_16
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Book: The molecular basis of neurosurgical disease / 8

    Raffel, Corey

    1996  

    Author's details ed. Corey Raffel
    Collection The molecular basis of neurosurgical disease
    Language English
    Size XV, 393 S. : Ill., graph. Darst.
    Publisher Williams & Wilkins
    Publishing place Baltimore u.a.
    Publishing country United States
    Document type Book
    HBZ-ID HT008804438
    ISBN 0-683-18312-5 ; 978-0-683-18312-2
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  3. Article ; Online: Cerebellar tonsil position and Chiari malformation.

    Raffel, Corey

    Journal of neurosurgery

    2013  Volume 119, Issue 3, Page(s) 810–811

    MeSH term(s) Arnold-Chiari Malformation/pathology ; Cerebellum/pathology ; Female ; Humans ; Male ; Registries
    Language English
    Publishing date 2013-09
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 3089-2
    ISSN 1933-0693 ; 0022-3085
    ISSN (online) 1933-0693
    ISSN 0022-3085
    DOI 10.3171/2013.3.JNS1339
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Editorial: glioblastoma subtype.

    Raffel, Corey

    Journal of neurosurgery

    2012  Volume 117, Issue 3, Page(s) 474; discussion 475

    MeSH term(s) Biomarkers, Tumor/metabolism ; Female ; Glioblastoma/classification ; Glioblastoma/diagnosis ; Humans ; Male ; Neurofilament Proteins/metabolism ; Neurons/metabolism ; Supratentorial Neoplasms/classification ; Supratentorial Neoplasms/diagnosis
    Chemical Substances Biomarkers, Tumor ; Neurofilament Proteins
    Language English
    Publishing date 2012-09
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 3089-2
    ISSN 1933-0693 ; 0022-3085
    ISSN (online) 1933-0693
    ISSN 0022-3085
    DOI 10.3171/2012.1.JNS112254
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Using Cystine Knot Proteins as a Novel Approach to Retarget Oncolytic Measles Virus.

    Lal, Sangeet / Raffel, Corey

    Molecular therapy oncolytics

    2017  Volume 7, Page(s) 57–66

    Abstract: Modified measles virus (MV) has effective oncolytic activity preclinically and is currently being investigated in clinical trials for various types of cancer. We investigated the use of cystine knot proteins (CKPs) to direct MV activity. CKPs are short ... ...

    Abstract Modified measles virus (MV) has effective oncolytic activity preclinically and is currently being investigated in clinical trials for various types of cancer. We investigated the use of cystine knot proteins (CKPs) to direct MV activity. CKPs are short polypeptides that bind their targets with high affinity. We used a CKP that binds αvβ3, αvβ5, and α5β1 integrins with single-digit nanomolar affinity to retarget MV to the integrins (MV-CKPint). MV-CKPint infected, replicated in, and killed human glioblastoma, medulloblastoma, diffuse intrinsic pontine glioma (DIPG), and melanoma cancer cells in vitro, all of which express the target integrins. MV-CKPint activity was competitively blocked by echistatin, an integrin binding peptide. When the CKP was cleaved from the viral H protein at an included protease site, virus activity was abrogated. When delivered intravenously (i.v.), the retargeted virus reached a subcutaneous glioblastoma tumor bed and produced cytopathic effects similar to that shown by intratumoral injection of the virus. Because these target integrins are overexpressed by tumor vascular endothelium, MV-CKPint may allow for effective therapy with i.v. injection. These results indicate for the first time that CKPs can be used to retarget MV for a receptor of choice. In addition, MV-CKPint provides proof of principle for the use of a CKP of interest to retarget any enveloped virus for both oncolytic and gene therapy purposes.
    Language English
    Publishing date 2017-09-29
    Publishing country United States
    Document type Journal Article
    ISSN 2372-7705
    ISSN 2372-7705
    DOI 10.1016/j.omto.2017.09.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Pediatric brain abscesses.

    Raffel, Corey

    Neurosurgical focus

    2008  Volume 24, Issue 6, Page(s) E5

    MeSH term(s) Age Factors ; Brain Abscess/diagnosis ; Brain Abscess/therapy ; Child ; Humans
    Language English
    Publishing date 2008
    Publishing country United States
    Document type Editorial
    ZDB-ID 2026589-X
    ISSN 1092-0684 ; 1092-0684
    ISSN (online) 1092-0684
    ISSN 1092-0684
    DOI 10.3171/FOC/2008/24/6/E5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Complications following preresection shunting in patients with posterior fossa tumors.

    Ostling, Lauren / Raffel, Corey

    Journal of neurosurgery. Pediatrics

    2015  Volume 15, Issue 1, Page(s) 1–3

    MeSH term(s) Female ; Humans ; Hydrocephalus/surgery ; Infratentorial Neoplasms/complications ; Male ; Neuroendoscopy ; Tomography, X-Ray Computed ; Ventriculoperitoneal Shunt/adverse effects ; Ventriculostomy/adverse effects
    Language English
    Publishing date 2015-01
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 2403985-8
    ISSN 1933-0715 ; 1933-0707
    ISSN (online) 1933-0715
    ISSN 1933-0707
    DOI 10.3171/2014.9.PEDS14440
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Suprasellar Germinoma Presenting with Slipped Capital Femoral Epiphysis: Case Report.

    Sankar, Keerthana / Kyono, Wade / Raffel, Corey / Nicolaides, Theodore

    Cureus

    2017  Volume 9, Issue 12, Page(s) e1954

    Abstract: Slipped capital femoral epiphysis (SCFE) is a fracture that results from displacement of the proximal femoral epiphysis from the femoral neck. SCFE can be caused by various endocrinopathies that lead to bone weakening in both adult and pediatric patients. ...

    Abstract Slipped capital femoral epiphysis (SCFE) is a fracture that results from displacement of the proximal femoral epiphysis from the femoral neck. SCFE can be caused by various endocrinopathies that lead to bone weakening in both adult and pediatric patients. We report a rare case of suprasellar germinoma presenting with SCFE in an 11-year-old female patient. The findings of this case further support the need to consider pituitary lesions as the underlying cause of endocrine deficiences leading to SCFE.
    Language English
    Publishing date 2017-12-16
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2747273-5
    ISSN 2168-8184
    ISSN 2168-8184
    DOI 10.7759/cureus.1954
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Medulloblastoma: molecular genetics and animal models.

    Raffel, Corey

    Neoplasia (New York, N.Y.)

    2004  Volume 6, Issue 4, Page(s) 310–322

    Abstract: Medulloblastoma is a primary brain tumor found in the cerebellum of children. The tumor occurs in association with two inherited cancer syndromes: Turcot syndrome and Gorlin syndrome. Insights into the molecular biology of the tumor have come from ... ...

    Abstract Medulloblastoma is a primary brain tumor found in the cerebellum of children. The tumor occurs in association with two inherited cancer syndromes: Turcot syndrome and Gorlin syndrome. Insights into the molecular biology of the tumor have come from looking at alterations in the genes altered in these syndromes, PTC and APC, respectively. Murine models of medulloblastoma have been constructed based on these alterations. Additional murine models that, while mimicking the appearance of the human tumor, seem unrelated to the human tumor's molecular alterations have been made. In this review, the clinical picture, origin, molecular biology, and murine models of medulloblastoma are discussed. Although a great deal has been discovered about this tumor, the genetic alterations responsible for tumor development in a majority of patients have yet to be described.
    MeSH term(s) Animals ; Cerebellar Neoplasms/genetics ; Cerebellar Neoplasms/pathology ; Cerebellar Neoplasms/therapy ; Disease Models, Animal ; Humans ; Medulloblastoma/genetics ; Medulloblastoma/pathology ; Medulloblastoma/therapy
    Language English
    Publishing date 2004-07
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1483840-0
    ISSN 1522-8002
    ISSN 1522-8002
    DOI 10.1593/neo.03454
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Advances in the design and development of oncolytic measles viruses.

    Hutzen, Brian / Raffel, Corey / Studebaker, Adam W

    Oncolytic virotherapy

    2015  Volume 4, Page(s) 109–118

    Abstract: A successful oncolytic virus is one that selectively propagates and destroys cancerous tissue without causing excessive damage to the normal surrounding tissue. Oncolytic measles virus (MV) is one such virus that exhibits this characteristic and thus has ...

    Abstract A successful oncolytic virus is one that selectively propagates and destroys cancerous tissue without causing excessive damage to the normal surrounding tissue. Oncolytic measles virus (MV) is one such virus that exhibits this characteristic and thus has rapidly emerged as a potentially useful anticancer modality. Derivatives of the Edmonston MV vaccine strain possess a remarkable safety record in humans. Promising results in preclinical animal models and evidence of biological activity in early phase trials contribute to the enthusiasm. Genetic modifications have enabled MV to evolve from a vaccine agent to a potential anticancer therapy. Specifically, alterations of the MV genome have led to improved tumor selectivity and delivery, therapeutic potency, and immune system modulation. In this article, we will review the advancements that have been made in the design and development of MV that have led to its use as a cancer therapy. In addition, we will discuss the evidence supporting its use, as well as the challenges associated with MV as a potential cancer therapeutic.
    Language English
    Publishing date 2015-08-27
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 2799361-9
    ISSN 2253-1572
    ISSN 2253-1572
    DOI 10.2147/OV.S66078
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top